These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 8840961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 3. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
    Kawamori T, Rao CV, Seibert K, Reddy BS.
    Cancer Res; 1998 Feb 01; 58(3):409-12. PubMed ID: 9458081
    [Abstract] [Full Text] [Related]

  • 4. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 5. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV, Hirose Y, Indranie C, Reddy BS.
    Cancer Res; 2001 Mar 01; 61(5):1927-33. PubMed ID: 11280748
    [Abstract] [Full Text] [Related]

  • 6. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, El-Bayoumy K, Reddy BS.
    Cancer Res; 2001 May 01; 61(9):3647-52. PubMed ID: 11325834
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
    Raju J, Bird RP.
    Cancer Res; 2003 Oct 15; 63(20):6595-601. PubMed ID: 14583451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.
    Kawamori T, Uchiya N, Kitamura T, Ohuchida S, Yamamoto H, Maruyama T, Sugimura T, Wakabayashi K.
    Anticancer Res; 2001 Oct 15; 21(6A):3865-9. PubMed ID: 11911260
    [Abstract] [Full Text] [Related]

  • 12. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
    Singh J, Hamid R, Reddy BS.
    Cancer Res; 1997 Aug 15; 57(16):3465-70. PubMed ID: 9270014
    [Abstract] [Full Text] [Related]

  • 13. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS.
    Cancer Res; 1997 Apr 01; 57(7):1301-5. PubMed ID: 9102217
    [Abstract] [Full Text] [Related]

  • 14. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y, Morisawa T, Hosoda A, Shiota G, Kawasaki H, Hasegawa J.
    J Exp Clin Cancer Res; 2002 Jun 01; 21(2):203-11. PubMed ID: 12148579
    [Abstract] [Full Text] [Related]

  • 15. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.
    Takahashi M, Fukutake M, Yokota S, Ishida K, Wakabayashi K, Sugimura T.
    J Cancer Res Clin Oncol; 1996 Jun 01; 122(4):219-22. PubMed ID: 8601574
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemopreventive effect of squalene on colon cancer.
    Rao CV, Newmark HL, Reddy BS.
    Carcinogenesis; 1998 Feb 01; 19(2):287-90. PubMed ID: 9498278
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
    Suzuki R, Yasui Y, Kohno H, Miyamoto S, Hosokawa M, Miyashita K, Tanaka T.
    Oncol Rep; 2006 Nov 01; 16(5):989-96. PubMed ID: 17016582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.